Hims & Hers Health Stock Slides 15%+ Intraday on Short Report from Hunterbrook
Hims & Hers Health Stock Slides 15%+ Intraday on Short Report from Hunterbrook
$Hims & Hers Health (HIMS.US)$ sank more than 15% intraday Thursday after Hunterbrook issued a so-called "short report" on the mail-order-drug retailer.
$Hims & Hers Health (HIMS.US)$邮购药品零售商受到 Hunterbrook 的所谓"空头报告"的影响，在周四盘中下跌超过15%。
HIMS fell as much as 16.5% to an $18.80 intraday low after Hunterbrook released a bearish report on Thursday, alleging problems with Hims & Hers' recent moves to sell hot GLP-1 weight loss drugs.
Hunterbrook在周四发布了看淡报告，指称 HIMS 最近销售热门 GLP-1 减肥药存在问题，导致其股价下跌了高达 16.5%，至18.8美元的盘中低点。
Benzinga reached out to Hims & Hers Health for comment and received a response from a spokesperson highlighting a post on the company's commitment to customer safety and another post on how the company is delivering safe access to GLP-1 injections.
本文已联系 Hims & Hers Health 进行评论，并从一位发言人处收到回复，强调了公司对客户安全的承诺，以及公司如何提供安全使用 GLP-1 注射剂的功能。
Hunterbrook operates under two different arms: Hunterbrook Media and Hunterbrook Capital.
Hunterbrook 有两个不同的部门：Hunterbrook Media 和 Hunterbrook Capital。前者作为一个媒体机构，发布全球新闻报道。后者作为一个投资基金，通过赌博一些研究报告中的股票方向进行盈利。
The former operates as a media outlet publishing investigative and global reporting. The latter arm is a hedge fund that bets for or against some of the stocks on which it reports. Hunterbrook has announced that it has a short position in Hims & Hers Health stock.
Hunterbrook 宣布在 Hims & Hers Health 的股票中有空头头寸。